Endometrial Cancer
📧 Sign up to get email alerts when something new happens for Endometrial Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-02-24Clinical Trial Update: A.I and Machine Learning Based Risk Prediction Model to Improve the Clinical Management of Endometrial Cancer.
A clinical trial is evaluating an AI and machine learning-based risk prediction model to improve the clinical management of endometrial canc…
-
CLINICAL_TRIALS research · 2025-02-21Clinical Trial Update: Genetic Testing in African Americans [NA]
Clinical trial update on genetic testing in African American participants related to ovarian cancer, endometrial cancer, and peritoneal canc…
-
CLINICAL_TRIALS research · 2025-02-19Clinical Trial Update: Sentinel Lymph Node Sampling for Patients With Middle-high Risk Endometrial Cancer Confined to the Uterus [NA]
Clinical trial status update for a study evaluating sentinel lymph node sampling in middle-high risk endometrial cancer confined to the uter…
-
CLINICAL_TRIALS research · 2025-02-07Clinical Trial Update: A Study of XmAb20717 (Vudalimab)in Patients With Selected Advanced Gynecologic and Genitourinary Malignancies [Phase 2]
This clinical trial update reports on a Phase 2 study of XmAb20717 (Vudalimab) in selected advanced gynecologic and genitourinary cancers, w…
-
CLINICAL_TRIALS research · 2025-01-30Clinical Trial Update: Evaluating Efficacy and Tolerability of Anticancer Drug Therapies for the Treatment of Gynecologic and Breast Cancers
This clinical trial update shows recruitment for evaluating efficacy and tolerability of anticancer drug therapies in breast and gynecologic…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-01-30Clinical Trial Update: Methylated Biomarkers Predictive of Endometrial Cancer Risk
A clinical trial update from the University of Manchester describes methylated biomarkers that may predict endometrial cancer risk. The stud…
-
CLINICAL_TRIALS research · 2025-01-23Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of HB0025 Injection in Patients With Advanced Solid Tumor [Phase 1, Phase 2]
A Phase 1/2 clinical trial assessing the safety and preliminary efficacy of HB0025 injection in patients with advanced solid tumors, includi…
-
CLINICAL_TRIALS research · 2025-01-17Clinical Trial Update: Effect of Motivational Interviewing on Posttraumatic Stress Symptoms and Posttraumatic Growth in Women with Endometrial Cancer [NA]
A clinical trial investigating whether motivational interviewing reduces post-traumatic stress symptoms and enhances posttraumatic growth am…
-
CLINICAL_TRIALS research · 2025-01-14Clinical Trial Update: Multimodal PET Imaging in the Diagnosis and Treatment of Pelvic Tumors [NA]
A multimodal PET imaging study for the diagnosis and treatment of pelvic tumors in endometrial cancer is currently recruiting at Peking Unio…
-
CLINICAL_TRIALS research · 2025-01-13Clinical Trial Update: Adebrelimab Plus Carboplatin/Paclitaxel Followed by Adebelizumab with or Without Apatinib in the Treatment of Advanced Recurrent/Metastatic Endometrial Cancer (A-CAPE): a Multicenter, Randomized, Controlled, Open-Label Clinical Trial [Phase 2]
A Phase 2 multicenter randomized open-label trial evaluating adebrelimab plus carboplatin/paclitaxel followed by adebelizumab, with or witho…
-
CLINICAL_TRIALS research · 2025-01-07Clinical Trial Update: Study of Fruquintinib Plus Sintilimab for Treatment of Advanced Endometrial Cancer [Phase 3]
Phase 3 study evaluating Fruquintinib in combination with Sintilimab for advanced endometrial cancer is currently recruiting.
-
CLINICAL_TRIALS research · 2025-01-07Clinical Trial Update: Comparison of Five-year Survival and Disease-free Survival in Patients Diagnosed With Endometrium Cancer Who Underwent Total Laparoscopic Hysterectomy With and Without Uterine Manipulator
Clinical trial update evaluating five-year overall survival and disease-free survival in endometrial cancer patients undergoing total laparo…
-
CLINICAL_TRIALS research · 2024-12-27Clinical Trial Update: QL1706 Combined with Chemotherapy in the Treatment of Recurrent or Metastatic Endometrial Cancer [Phase 2]
Phase 2 clinical trial evaluating QL1706 in combination with chemotherapy for recurrent or metastatic endometrial cancer; status is not yet …
-
CLINICAL_TRIALS research · 2024-12-20Clinical Trial Update: A Multi-center Prospective Study on the Oncological and Reproductive Outcomes and Quality of Life in Young Woman After Fertility-sparing Treatment of Endometrial Cancer and Endometrial Intraepithelial Hyperplasia
Describes a multi-center prospective study evaluating oncological outcomes, reproductive outcomes, and quality of life after fertility-spari…
-
CLINICAL_TRIALS research · 2024-12-17Clinical Trial Update: Evaluation of Clinical and Molecular Biomarkers in Immunotherapy Treatment in Gynecologic Cancer
This entry reports on a clinical trial evaluating clinical and molecular biomarkers in immunotherapy treatment for gynecologic cancers, focu…
-
CLINICAL_TRIALS research · 2024-12-16Clinical Trial Update: Prognostic and Diagnostic Added Value of Medical Imaging in Gynecological Cancer (PRODIGYN)
The PRODIGYN study is a prospective trial evaluating the added prognostic and diagnostic value of medical imaging in gynecologic cancers and…
-
CLINICAL_TRIALS research · 2024-12-11Clinical Trial Update: Comprehensive Outcomes for After Cancer Health [NA]
A clinical trial update from Pack Health indicates the study on comprehensive outcomes for after-cancer health is currently recruiting, cove…
-
CLINICAL_TRIALS research · 2024-12-10Clinical Trial Update: Akynzeo as Antiemetic Treatment in Patients With Endometrial Cancer [Phase 4]
A Phase 4 clinical trial is evaluating Akynzeo (netupitant/palonosetron) as an antiemetic in patients with endometrial cancer and is current…
-
CLINICAL_TRIALS research · 2024-12-06Clinical Trial Update: PErsonalized TReatment for Endometrial Carcinoma [NA]
A University of Helsinki-sponsored clinical trial is currently recruiting to evaluate personalized treatment for endometrial adenocarcinoma.
-
CLINICAL_TRIALS research · 2024-12-03Clinical Trial Update: SATELLITE Study (feaSibility sAfeTy Efficacy dostarLimab earLy-stage defIcient endomeTrial cancEr) [Phase 2]
A Phase 2 feasibility study (SATELLITE) evaluating dostarlimab in early-stage endometrial cancer with mismatch repair deficiency; recruitmen…
-
CLINICAL_TRIALS research · 2024-11-29Clinical Trial Update: Refining Adjuvant Treatment IN Endometrial Cancer Based On Molecular Features [Phase 2, Phase 3]
This trial update describes ongoing Phase 2/Phase 3 efforts to refine adjuvant treatment for endometrial cancer based on molecular features.
-
CLINICAL_TRIALS research · 2024-11-26Clinical Trial Update: Collection of Endometrial Cancer-derived Organoids to Evaluate the Efficacy of PARP Inhibitors: PENDOR Pilot Study
This ClinicalTrials.gov entry describes a pilot study collecting endometrial cancer-derived organoids to evaluate the efficacy of PARP inhib…
-
CLINICAL_TRIALS research · 2024-11-25Clinical Trial Update: Endometrial Cancer Lymphadenectomy Trial [NA]
A clinical trial evaluating lymphadenectomy for endometrial cancer is currently recruiting, sponsored by Philipps University Marburg, focusi…
-
CLINICAL_TRIALS research · 2024-11-25Clinical Trial Update: Sentinel Lymph Node in Early-Stage Endometrium Cancer [NA]
This entry notes a recruiting clinical trial studying sentinel lymph node procedures in patients with early-stage endometrial cancer.
-
CLINICAL_TRIALS research · 2024-11-21Clinical Trial Update: Study of Pembrolizumab (MK-3475) Versus Chemotherapy in Mismatch Repair Deficient (dMMR) Advanced or Recurrent Endometrial Carcinoma (MK-3475-C93/KEYNOTE-C93/GOG-3064/ENGOT-en15) [Phase 3]
A Phase 3 trial evaluating pembrolizumab versus chemotherapy in mismatch repair-deficient advanced or recurrent endometrial cancer; the stud…